150 related articles for article (PubMed ID: 920688)
1. Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstones.
Marks JW; Bonorris GG; Chung A; Coyne MJ; Okun R; Lachin JM; Schoenfield LJ
Am J Dig Dis; 1977 Oct; 22(10):856-60. PubMed ID: 920688
[TBL] [Abstract][Full Text] [Related]
2. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
[TBL] [Abstract][Full Text] [Related]
3. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
Iser JH; Murphy GM; Dowling RH
Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
[TBL] [Abstract][Full Text] [Related]
4. Interaction of chenodeoxycholic acid and dietary cholesterol in the treatment of cholesterol gallstones.
Doty JE; DenBesten L; Roslyn JJ; Pitt HA; Kuchenbecker SL; Porter-Fink V
Am J Surg; 1982 Jan; 143(1):48-54. PubMed ID: 7053655
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
7. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
[TBL] [Abstract][Full Text] [Related]
8. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
Reuben A; Maton PN; Murphy GM; Dowling RH
Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
[TBL] [Abstract][Full Text] [Related]
9. Medical management of cholesterol gallstones.
Abate MA
Drug Intell Clin Pharm; 1986 Feb; 20(2):106-15. PubMed ID: 3512222
[TBL] [Abstract][Full Text] [Related]
10. Desaturation of bile and cholesterol gallstone dissolution with chenodeoxycholic acid.
Hofmann AF
Am J Clin Nutr; 1977 Jun; 30(6):993-1000. PubMed ID: 326024
[TBL] [Abstract][Full Text] [Related]
11. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
Grundy SM; Lan SP; Lachin J
J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
[TBL] [Abstract][Full Text] [Related]
12. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
Reuben A; Qureshi Y; Murphy GM; Dowling RH
Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
[TBL] [Abstract][Full Text] [Related]
13. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.
Barbara L; Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R
Digestion; 1976; 14(3):209-19. PubMed ID: 955328
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
[No Abstract] [Full Text] [Related]
15. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
16. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
17. [Changes in bile and blood lipid levels following chenodeoxycholic acid therapy].
Barbara L; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Sorci F; Roda E
Minerva Med; 1977 Sep; 68(43):3023-6. PubMed ID: 909650
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
19. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
Iser JH; Dowling H; Mok HY; Bell GD
N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
